Johnson & Johnson's press release — JNJ's reaction is being measured
JNJ's realized reaction is still being measured.
· PR Newswire · Press release · Realized reaction, point-in-time, zero look-ahead.
Johnson & Johnson announces new Phase 2 nipocalimab study data in Sjögren's disease that reveal insights on importance of symptom improvements most valued by patients
Via PR Newswire
Reaction is being measured.
This event is recent. News Quantified labels the realized price reaction once the trading sessions after the news complete — point-in-time, with zero look-ahead. The measured move will appear here, and below in JNJ’s reaction history.
Where this JNJ event came from, and what the tape did with it.
Johnson & Johnson issued a press release, carried via PR Newswire, on Nov 7, 2026. It was one of 2 Johnson & Johnson headlines News Quantified labeled that day, so its measurement window overlaps with the others on a shared tape. The same session also carried Johnson & Johnson's "Johnson & Johnson announces ICOTYDE® (icotrokinra) delivers…", each measured on its own clock.
Against the price at the news timestamp, JNJ's reaction is still being measured. Because several releases shared that day, their measurement windows overlap and no single headline cleanly owns the move.
How this compares to JNJ’s usual reaction.
Across 2,000+ labeled events, JNJ’s median 30-minute reaction to all news is +0.06% (56% up); by the close it is +0.06%.
| Middle 50% of JNJ reactions | -0.26% to +0.39% |
|---|---|
| Median reaction (30-min) | +0.06% |
| Measured reactions | 2,000+ |
Half of all Johnson & Johnson news events land between -0.26% and +0.39% at 30 minutes; this one is a single draw from that distribution.
You just saw one reaction. There are 26M+ more.
See the full JNJ reaction history →Email me when JNJ moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to JNJ's baseline. Nothing else.
How comparable JNJ events have landed.
Across 5 other recent Johnson & Johnson press release events, the median close-day reaction was -0.53%. Each is measured the same way, from its own news timestamp.
8 more JNJ events, each measured the same way.
Recent JNJ events, each with its measured reaction8
Across the market6
Same measurement, same clock, different names — each headline measured from its own news timestamp, point-in-time.
Peer tickers, measured the same way4
| Ticker | Most recent event | 5-min | To close |
|---|---|---|---|
| Eli Lilly (LLY) | Lilly and Hims & Hers expand access to FDA-approved Lilly medicines | +1.02% | +0.64% |
| UnitedHealth Group (UNH) | UnitedHealth Group Board Authorizes Payment of Quarterly Dividend | -0.30% | +3.38% |
| Apple (AAPL) | Form 10-K Apple Inc. For: Sep 26 | +0.29% | +1.89% |
| NVIDIA (NVDA) | Election Day Trading Splits the Benchmarks, With the Dow Lower and the Nasdaq Higher | +0.01% | -0.67% |
Every US ticker is measured the same way, from its own news timestamp. Browse all tickers →
JNJ carried 1 other record that day.
Each was measured the same way, from its own timestamp.
How the numbers are made.
How was JNJ's 5-minute reaction measured?
From the news timestamp, not the trading day: News Quantified takes the last trade before this press release as the base price and measures the move five minutes of trading later — point-in-time, zero look-ahead. The same clock produced the to-close figure.
What is Johnson & Johnson's median reaction, and how does this event compare?
Johnson & Johnson's median is drawn from 2,000+ labeled events; at 30 minutes it sits at +0.06%, and +0.06% by the close. This event's move is one draw from that distribution — ordinary or outlier, the chart's median ticks show which.
2 Johnson & Johnson headlines shared Nov 7, 2026. Whose reaction is this?
Each of the 2 same-day Johnson & Johnson events is measured from its own timestamp, but their windows overlap on one tape, so we show the cluster rather than pretending a single headline owns the move.
Does a measured reaction predict Johnson & Johnson's next reaction?
No. a measured reaction is a realized fact about Nov 7, 2026, not a forecast. Past reactions describe a distribution; they say nothing certain about any future move.
How to cite this reaction.
News Quantified. "Johnson & Johnson announces new Phase 2 nipocalimab study data in Sjögren's disease that reveal insights on importance of symptom improvements most valued by patients." JNJ realized price reaction, Nov 7, 2026. Retrieved from https://newsquantified.com/tickers/jnj/news/johnson-johnson-announces-new-phase-2-nipocalimab-study-2026-11-07
Canonical URL: https://newsquantified.com/tickers/jnj/news/johnson-johnson-announces-new-phase-2-nipocalimab-study-2026-11-07
Query this dataset via the API & MCP →